Patrick Forde: Results of 1st platform neoadjuvant IO trial in lung cancer led by Dr. Tina Cascone!

Quoting Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, on X/Twitter:

”Results of 1st platform neoadjuvant IO trial in lung cancer led by Dr. Tina Cascone! We believe this trial design and in depth science will deliver valuable and rapid info to prioritize new IO agents in early and late stage cancer. NeoCOAST2 already underway!”

For the information click here.
Source: Patrick Forde/Twitter